Andrea Baer: Reducing Barriers to Medication Access and Adherence - A Peer-to-Peer Community-Based Approach

Presentation by Andrea Baer, MS, director of Patient Advocacy, Mended Hearts, Inc, at the Cost-Sharing Roundtable: Sustainable Strategies for Providing Access to Critical Medications. The event was co-hosted by the PAN Foundation and The American Journal of Managed Care®.

Related Videos

Related Content

Advertisement

July 24th 2025

Addressing Acne in Patients of Color

Pearl Steinzor

Culturally informed, patient-centered strategies are needed to address acne and hyperpigmentation in patients with skin of color.

Published: July 15th 2025 | Updated: July 15th 2025

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Giuliana Grossi Sadie Dobrozsi, MD, MS Interview by Mary Caffrey

Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization

July 24th 2025

Prevalence and Inclusiveness of Pay-for-Performance Incentives for HPV Vaccination

Justin G. Trogdon, PhD Kathryn R. Brignole, MS Ben Fogel, MD, MPH Tara Licciardello Queen, PhD

This article examines the prevalence of pay-for-performance incentives to promote human papillomavirus vaccination and other quality metrics as reported by frontline clinical staff.

July 1st 2025

Why Collaborative Care Is the Path Forward for Mental Health Care: Anna Bobb, MPH

Giuliana Grossi Anna Bobb, MPH

Explore how the Collaborative Care Model enhances mental health access in this episode featuring Anna Bobb, MPH, executive director of the Path Forward coalition.

July 23rd 2025

Insulin Nasal Spray Reaches Memory Centers in Brain, Offering Hope for Alzheimer Treatment

Hayden E. Klein

The 16-person, first-in-human study showed promising safety and efficacy data for delivering insulin intranasally in older adults.

July 23rd 2025

The Evolving Landscape of Myasthenia Gravis Therapies: A Q&A With Miriam Freimer, MD

Maggie L. Shaw Miriam Freimer, MD

Miriam Freimer, MD, clinical professor of neurology at The Ohio State University Wexner Medical Center, reflects on how findings from the RAISE-XT trial potentially translate to real-world practice and looks to the future of treatment for the autoimmune neuromuscular disorder.

Related Content

Advertisement

July 24th 2025

Addressing Acne in Patients of Color

Pearl Steinzor

Culturally informed, patient-centered strategies are needed to address acne and hyperpigmentation in patients with skin of color.

Published: July 15th 2025 | Updated: July 15th 2025

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Giuliana Grossi Sadie Dobrozsi, MD, MS Interview by Mary Caffrey

Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization

July 24th 2025

Prevalence and Inclusiveness of Pay-for-Performance Incentives for HPV Vaccination

Justin G. Trogdon, PhD Kathryn R. Brignole, MS Ben Fogel, MD, MPH Tara Licciardello Queen, PhD

This article examines the prevalence of pay-for-performance incentives to promote human papillomavirus vaccination and other quality metrics as reported by frontline clinical staff.

July 1st 2025

Why Collaborative Care Is the Path Forward for Mental Health Care: Anna Bobb, MPH

Giuliana Grossi Anna Bobb, MPH

Explore how the Collaborative Care Model enhances mental health access in this episode featuring Anna Bobb, MPH, executive director of the Path Forward coalition.

July 23rd 2025

Insulin Nasal Spray Reaches Memory Centers in Brain, Offering Hope for Alzheimer Treatment

Hayden E. Klein

The 16-person, first-in-human study showed promising safety and efficacy data for delivering insulin intranasally in older adults.

July 23rd 2025

The Evolving Landscape of Myasthenia Gravis Therapies: A Q&A With Miriam Freimer, MD

Maggie L. Shaw Miriam Freimer, MD

Miriam Freimer, MD, clinical professor of neurology at The Ohio State University Wexner Medical Center, reflects on how findings from the RAISE-XT trial potentially translate to real-world practice and looks to the future of treatment for the autoimmune neuromuscular disorder.